Abstract
An 18 year old girl presented with a leiomyosarcoma of the small bowel with widespread dissemination. Despite short term remissions after chemotherapy and surgery she died of the disease 10 months later. A history of prolonged exposure to danthron (an anthraquinone laxative) in childhood was obtained. Anthraquinones are known to be mutagenic and may be carcinogenic in experimental systems but danthron is not a proven carcinogen in man. The association of danthron and a rare bowel cancer in one case cannot prove a causative link. However, collection of further data seems advisable.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown J. P., Brown R. J. Mutagenesis by 9,10-anthraquinone derivatives and related compounds in Salmonella typhimurium. Mutat Res. 1976 Jul;40(3):203–224. doi: 10.1016/0165-1218(76)90046-x. [DOI] [PubMed] [Google Scholar]
- Gardiner J. S., Walker S. A., MacLean A. J. A retrospective mortality study of substituted anthraquinone dyestuffs workers. Br J Ind Med. 1982 Nov;39(4):355–360. doi: 10.1136/oem.39.4.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mori H., Sugie S., Niwa K., Takahashi M., Kawai K. Induction of intestinal tumours in rats by chrysazin. Br J Cancer. 1985 Nov;52(5):781–783. doi: 10.1038/bjc.1985.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tikkanen L., Matsushima T., Natori S. Mutagenicity of anthraquinones in the Salmonella preincubation test. Mutat Res. 1983 Mar;116(3-4):297–304. doi: 10.1016/0165-1218(83)90067-8. [DOI] [PubMed] [Google Scholar]